Search research articles
Contact Us
Filters
Showing results (81-90 of 152) with videos related to
Page
of 16
Sort By:
Gastro Hep Advances
|
March 8, 2024
Factors That Predict Magnitude, Timing, and Persistence of Placebo-Like Response in Patients With Irritable Bowel Syndrome
Jeffrey M Lackner, Brian M Quigley, Sigal Zilcha-Mano, et al.
ACS Biomaterials Science & Engineering
|
January 19, 2021
Rolling or Two-Stage Aggregation of Platelets on the Surface of Thin Ceramic Coatings under in Vitro Simulated Blood Flow Conditions
Aldona Mzyk, Gabriela Imbir, Klaudia Trembecka-Wójciga, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 3, 2020
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
M Bassetti, A Vena, E Bouza, et al.
Medical Mycology
|
October 19, 2011
Molecular identification tools for sibling species of Scedosporium and Pseudallescheria
M Lackner, C H Klaassen, J F Meis, et al.
Journal of Functional Biomaterials
|
June 24, 2014
Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers
Juergen M Lackner, Wolfgang Waldhauser, Paul Hartmann, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2014
Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment
M Lackner, M Tscherner, M Schaller, et al.
Psychosomatic Medicine
|
March 24, 2006
Measuring health-related quality of life in patients with irritable bowel syndrome: can less be more?
Jeffrey M Lackner, Gregory D Gudleski, Matthew M Zack, et al.
Contemporary Clinical Trials
|
August 1, 2012
The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome
Jeffrey M Lackner, Laurie Keefer, James Jaccard, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2025
Telomeric SUMO level influences the choices of APB formation pathways and ALT efficiency
Rongwei Zhao, Allison Wivagg, Rachel M Lackner, et al.
BMC Gastroenterology
|
January 4, 2014
Detection of drug effects on gastric emptying and contractility using a wireless motility capsule
Inna Rozov-Ung, Amjad Mreyoud, John Moore, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 152) with videos related to
Sort By:
Page
of 16
Gastro Hep Advances
|
March 8, 2024
Factors That Predict Magnitude, Timing, and Persistence of Placebo-Like Response in Patients With Irritable Bowel Syndrome
Jeffrey M Lackner, Brian M Quigley, Sigal Zilcha-Mano, et al.
ACS Biomaterials Science & Engineering
|
January 19, 2021
Rolling or Two-Stage Aggregation of Platelets on the Surface of Thin Ceramic Coatings under in Vitro Simulated Blood Flow Conditions
Aldona Mzyk, Gabriela Imbir, Klaudia Trembecka-Wójciga, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 3, 2020
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
M Bassetti, A Vena, E Bouza, et al.
Medical Mycology
|
October 19, 2011
Molecular identification tools for sibling species of Scedosporium and Pseudallescheria
M Lackner, C H Klaassen, J F Meis, et al.
Journal of Functional Biomaterials
|
June 24, 2014
Hemocompatibility of Inorganic Physical Vapor Deposition (PVD) Coatings on Thermoplastic Polyurethane Polymers
Juergen M Lackner, Wolfgang Waldhauser, Paul Hartmann, et al.
Antimicrobial Agents and Chemotherapy
|
April 16, 2014
Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment
M Lackner, M Tscherner, M Schaller, et al.
Psychosomatic Medicine
|
March 24, 2006
Measuring health-related quality of life in patients with irritable bowel syndrome: can less be more?
Jeffrey M Lackner, Gregory D Gudleski, Matthew M Zack, et al.
Contemporary Clinical Trials
|
August 1, 2012
The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome
Jeffrey M Lackner, Laurie Keefer, James Jaccard, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2025
Telomeric SUMO level influences the choices of APB formation pathways and ALT efficiency
Rongwei Zhao, Allison Wivagg, Rachel M Lackner, et al.
BMC Gastroenterology
|
January 4, 2014
Detection of drug effects on gastric emptying and contractility using a wireless motility capsule
Inna Rozov-Ung, Amjad Mreyoud, John Moore, et al.
Page
of 16